<DOC>
	<DOCNO>NCT03006055</DOCNO>
	<brief_summary>The GILUPI CellCollector® first vivo CTC isolation product worldwide CE approve . Application data CellCollector China available . The purpose clinical trial confirm validation safety CellCollector Chinese patient .</brief_summary>
	<brief_title>The Detection Circulating Tumor Cells ( CTCs ) Breast Cancer With Novel Vivo Device</brief_title>
	<detailed_description />
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Metastasis breast cancer confirm image examination Have agree undergo CTC analysis vivo ; ECOG：02 Nonmetastasis breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>